- Filed
- Feb 22, 2022 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2021 · Mar 31, 2021 | 4.63M sh |
| Operating Cash Flow | Q1 2021 · Mar 31, 2021 | −$929.08K |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $1.12M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $293.18K |
| Stockholders Equity restated | Q1 2021 · Mar 31, 2021 | −$18.01M |
| Stockholders Equity | Q1 2021 · Dec 31, 2020 | $13.8K |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $202.18K |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $696.63K |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $19.59M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $696.63K |
| Current Assets | Q1 2021 · Mar 31, 2021 | $1.58M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $293.18K |
| Total Assets | Q1 2021 · Mar 31, 2021 | $213.22M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $710.43K |
| Eps Diluted | Q1 2021 · Mar 31, 2021 | −$0.07 |
| Eps Basic | Q1 2021 · Mar 31, 2021 | −$0.07 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.07 |
| Sga Expense | Q1 2021 · Mar 31, 2021 | $250.14K |
| Net Income | Q1 2021 · Mar 31, 2021 | −$705.24K |
| Net Income | Q1 2021 · Mar 31, 2020 | −$705.24K |
| Operating Income | Q1 2021 · Mar 31, 2021 | −$308.58K |